Investor Relations – Analyst Coverage
Dr Harry Shrives
Dr Adam McCarter
Immix Biopharma, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Immix Biopharma, Inc.’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Immix Biopharma, Inc.. or its management. Immix Biopharma, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. Immix Biopharma is a paid research client of Edison Investment Research Limited.